Follow
Tumor Targeting
Tumor Targeting: is a cancer treatment that uses drugs.... Targeted therapy works by targeting the cancer's specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. These genes and proteins are found in cancer cells or in cells related to cancer growth, like blood vessel cells.
What's Popular in Tumor Targeting
-
MAY 30, 2023Drug Discovery & DevelopmentIntroduction Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with ...MAY 25, 2023Immunology
A major research topic in medicine is to improve immune system function. The body responds to disease by activating cell ...Written By: Brian G. MorrealeMAY 24, 2023Immunology
Throughout the world, breast cancer is the most frequently diagnosed cancer type among women and is the leading cause of ...Written By: Brian G. MorrealeMAY 18, 2023Cancer
Metastatic cancer occurs when tumor cells spread from the original (or primary) cancer site to a distant location. ...Written By: Katie KokolusMAY 10, 2023Immunology
Myeloid-derived suppressor cells (MDSCs) are immune cells that promote chronic inflammatory disease, such as triple nega ...Written By: Brian G. Morreale
MAY 30, 2023
Drug Discovery & Development
Introduction Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with
...
MAY 25, 2023
Immunology
A major research topic in medicine is to improve immune system function. The body responds to disease by activating cell
...
Written By:
Brian G. Morreale
MAY 24, 2023
Immunology
Throughout the world, breast cancer is the most frequently diagnosed cancer type among women and is the leading cause of
...
Written By:
Brian G. Morreale
MAY 18, 2023
Cancer
Metastatic cancer occurs when tumor cells spread from the original (or primary) cancer site to a distant location.
...
Written By:
Katie Kokolus
MAY 10, 2023
Immunology
Myeloid-derived suppressor cells (MDSCs) are immune cells that promote chronic inflammatory disease, such as triple nega
...
Written By:
Brian G. Morreale
MAY 09, 2023
Immunology
Cancer immunotherapy constantly evolves, and discoveries and treatments targeting more aggressive cancers are published
...
Written By:
Brian G. Morreale
MAY 08, 2023
Cancer
Wilms tumor (also known as nephroblastoma), a type of kidney cancer most commonly diagnosed in children under five years
...
Written By:
Katie Kokolus
APR 27, 2023
Clinical & Molecular DX
Prostate cancer impacts men from all ethnic and racial groups, and has particularly high mortality rates compared to oth
...
Written By:
Carmen Leitch
APR 11, 2023
Cancer
Monoclonal antibodies have revolutionized cancer therapy since their introduction as therapeutics in the field. To enhan
...
Sponsored By:
Sino Biological
-
MAY 24, 2023 | 8:00 AM
Recent advances in multi-omic approaches, including genomics, transcriptomics, and proteomics, enable a more comprehensive description of the tumor. This promises to accelerate the developme...MAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...MAY 02, 2023 | 8:00 AMC.E. CREDITS
Abstract Learning Objectives Define a tertiary lymphoid structure in human cancer Describe the tumor microenvironment factors that influence the formation of tertiary lymphoid structures Ide...MAR 30, 2023 | 5:00 PM
Date: March 30, 2023 Time: 5:00pm (PST), 8:00pm (EST) March 31, 2023 9:00am (JST) Chimeric antigen receptor T cell (CAR-T) therapy is still challenging in targeting solid malignancies. The q...DEC 07, 2022 | 9:00 AMC.E. CREDITS
Date: December 07, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Join us for an exciting live panel webinar, as we celebrate the 60th anniversary of Gibco Cell Culture. The panelists...Speaker: Jessica Hess , Rukia Henry , Ernesto Goulart , Ameet Chimote, PhDSponsored By: Thermo Fisher Scientific/Gibco
MAY 24, 2023 | 8:00 AM
Recent advances in multi-omic approaches, including genomics, transcriptomics, and proteomics, enable a more comprehensive description of the tumor. This promises to accelerate the developme...
MAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...
MAY 02, 2023 | 8:00 AM
C.E. CREDITS
Abstract Learning Objectives Define a tertiary lymphoid structure in human cancer Describe the tumor microenvironment factors that influence the formation of tertiary lymphoid structures Ide...
MAR 30, 2023 | 5:00 PM
Date: March 30, 2023 Time: 5:00pm (PST), 8:00pm (EST) March 31, 2023 9:00am (JST) Chimeric antigen receptor T cell (CAR-T) therapy is still challenging in targeting solid malignancies. The q...
DEC 07, 2022 | 9:00 AM
C.E. CREDITS
Date: December 07, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Join us for an exciting live panel webinar, as we celebrate the 60th anniversary of Gibco Cell Culture. The panelists...
Speaker:
Jessica Hess
,
Rukia Henry
,
Ernesto Goulart
,
Ameet Chimote, PhD
Sponsored By: Thermo Fisher Scientific/Gibco
NOV 03, 2022 | 6:00 AM
Date: October 13, 2022 Time: 10:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Most known immune checkpoints exert their effects upon protein-protein interactions, such as the PD1 checkpoint on CD...
OCT 05, 2022 | 7:00 AM
C.E. CREDITS
Date: October 05, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) Cancer is a complex disease at the level of both cells and tissues, and uncovering novel treatments requires understan...
AUG 17, 2022 | 10:00 PM
Date: August 18, 2022 Time: 3pm AEST | 1pm SGT | 2pm JP/KR Kirsten rat sarcoma viral oncogene homologue (KRAS) is the most frequently mutated oncogene, present in approximately 25% of tumors...
MAY 25, 2022 | 10:00 AM
Date: May 25, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Programmable RNA base editors are excellent tools to modify RNA transcripts at precise locations or designated hotspots. P...
-
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
Labroots is pleased to announce the 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This 3 day event will take place on October 3-5, 2023....
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...MAR 01, 2023 | 10:00 AM PST
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...JAN 31, 2023 | 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
Labroots is pleased to announce the 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This 3 day event will take place on October 3-5, 2023....
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
MAR 01, 2023
| 10:00 AM PST
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
JAN 31, 2023
| 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
OCT 04, 2022
| 5:30 AM PDT
C.E. CREDITS
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....
JUN 22, 2022
| 3:00 AM PDT
Please join us for Ion World 2022, a virtual conference that will provide an opportunity to hear from scientists around the world, on how they are advancing research in a broad range of appl...
JAN 10, 2022
| 7:30 AM PST
Bionano Genomics is transforming the way the world sees the genome. The 2022 Symposium will feature usage of optical genome mapping in research, clinical research and clinical validation......